Imatinib treatment reduces brain injury in a murine model of traumatic brain injury

Frontiers in Cellular Neuroscience

Volumn 9, Issue OCT, 2015, Pages

  Su, Enming J ^a   Fredriksson, Linda ^a,b   Kanzawa, Mia ^a   Moore, Shannon ^a   Folestad, Erika ^b   Stevenson, Tamara K ^a   Nilsson, Ingrid ^b   Sashindranath, Maithili ^c   Schielke, Gerald P ^a   Warnock, Mark ^a   Ragsdale, Margaret ^a   Mann, Kris ^a   Lawrence, Anna Lisa E ^a   Medcalf, Robert L ^c   Eriksson, Ulf ^b   Murphy, Geoffrey G ^a   Lawrence, Daniel A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Blood brain barrier; Cerebral edema; Imatinib; Morris water maze; Platelet derived growth factor receptor ; Platelet derived growth factor CC; TBI outcome; Traumatic brain injury

Indexed keywords

IMATINIB; PLATELET DERIVED GROWTH FACTOR C;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CRANIOTOMY; DRUG EFFICACY; FEMALE; HUMAN; MALE; MORRIS WATER MAZE TEST; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYACRYLAMIDE GEL ELECTROPHORESIS; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING;

EID: 84944448434     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00385     Document Type: Article

References (60)

1. Abrams, M. B., Nilsson, I., Lewandowski, S. A., Kjell, J., Codeluppi, S., Olson, L., et al. (2012). Imatinib enhances functional outcome after spinal cord injury. PLoS One 7:e38760. doi: 10.1371/journal.pone.0038760
2. Adzemovic, M. Z., Zeitelhofer, M., Eriksson, U., Olsson, T., and Nilsson, I. (2013). Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response. PLoS One 8:e56586. doi: 10.1371/journal.pone.0056586
3. Bouma, G. J., Muizelaar, J. P., Choi, S. C., Newlon, P. G., and Young, H. F. (1991). Cerebral circulation and metabolism after severe traumatic brain injury: the elusive role of ischemia. J. Neurosurg. 75, 685-693. doi: 10.3171/jns.1991.75.5.0685
4. Bramlett, H. M., and Dietrich, W. D. (2004). Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J. Cereb. Blood Flow Metab. 24, 133-150. doi: 10.1097/01.wcb.0000111614.19196.04
5. Byrnes, K. R., Wilson, C. M., Brabazon, F., von Leden, R., Jurgens, J. S., Oakes, T. R., et al. (2014). FDG-PET imaging in mild traumatic brain injury: a critical review. Front. Neuroenergetics 5:13. doi: 10.3389/fnene.2013.00013
6. Cernak, I. (2005). Animal models of head trauma. NeuroRx 2, 410-422. doi: 10.1602/neurorx.2.3.410
7. Chodobski, A., Zink, B. J., and Szmydynger-Chodobska, J. (2011). Blood-brain barrier pathophysiology in traumatic brain injury. Transl. Stroke Res. 2, 492-516. doi: 10.1007/s12975-011-0125-x
8. Cohen, A. S., Pfister, B. J., Schwarzbach, E., Grady, M. S., Goforth, P. B., and Satin, L. S. (2007). Injury-induced alterations in CNS electrophysiology. Prog. Brain Res. 161, 143-169. doi: 10.1016/s0079-6123(06)61010-8
9. del Zoppo, G. J., and Mabuchi, T. (2003). Cerebral microvessel responses to focal ischemia. J. Cereb. Blood Flow Metab. 23, 879-894. doi: 10.1097/01.wcb.0000078322.96027.78
10. Dietrich, W. D., Alonso, O., and Halley, M. (1994). Early microvascular and neuronal consequences of traumatic brain injury: a light and electron microscopic study in rats. J. Neurotrauma 11, 289-301. doi: 10.1089/neu.1994.11.289
11. Dixon, C. E., Clifton, G. L., Lighthall, J. W., Yaghmai, A. A., and Hayes, R. L. (1991). A controlled cortical impact model of traumatic brain injury in the rat. J. Neurosci. Methods 39, 253-262. doi: 10.1016/0165-0270(91)90104-8
12. Finnie, J. W. (2014). Pathology of traumatic brain injury. Vet. Res. Commun. 38, 297-305. doi: 10.1007/s11259-014-9616-z
13. Fredriksson, L., Ehnman, M., Fieber, C., and Eriksson, U. (2005). Structural requirements for activation of latent platelet-derived growth factor CC by tissue plasminogen activator. J. Biol. Chem. 280, 26856-26862. doi: 10.1074/jbc.m503388200
14. Fredriksson, L., Li, H., Fieber, C., Li, X., and Eriksson, U. (2004). Tissue plasminogen activator is a potent activator of PDGF-CC. EMBO J. 23, 3793-3802. doi: 10.1038/sj.emboj.7600397
15. Fredriksson, L., Stevenson, T., Su, E., Ragsdale, M., Moore, S., Craciun, S., et al. (2015). Identification of a neurovascular signaling pathway regulating seizures in mice. Ann. Clin. Transl. Neurol. 2, 722-738. doi: 10.1002/acn3.209
16. Fridgeirsdottir, G. A., Hillered, L., and Clausen, F. (2014). Escalated handling of young C57BL/6 mice results in altered Morris water maze performance. Ups. J. Med. Sci. 119, 1-9. doi: 10.3109/03009734.2013.847511
17. Frieden, T. R., Houry, D., and Baldwin, G. (2014). The report to congress on traumatic brain injury in the united states: epidemiology and rehabilitation. Centers for disease control and prevention. Available online at: http://www.cdc.gov/traumaticbraininjury/pdf/TBI_Report_to_Congress_Epi_and_Rehab-a.pdf
18. Gallagher, M., Burwell, R., and Burchinal, M. (1993). Severity of spatial learning impairment in aging: development of a learning index for performance in the morris water maze. Behav. Neurosci. 107, 618-626. doi: 10.1037/0735-7044.107.4.618
19. Gilmer, L. K., Roberts, K. N., and Scheff, S. W. (2008). Efficacy of progesterone following a moderate unilateral cortical contusion injury. J. Neurotrauma 25, 593-602. doi: 10.1089/neu.2007.0477
20. Grumme, T., Baethmann, A., Kolodziejczyk, D., Krimmer, J., Fischer, M., von Eisenhart, R. B., et al. (1995). Treatment of patients with severe head injury by triamcinolone: a prospective, controlled multicenter clinical trial of 396 cases. Res. Exp. Med. (Berl) 195, 217-229. doi: 10.1007/bf02576791
21. Hall, E. D., Bryant, Y. D., Cho, W., and Sullivan, P. G. (2008). Evolution of post-traumatic neurodegeneration after controlled cortical impact traumatic brain injury in mice and rats as assessed by the de Olmos silver and fluorojade staining methods. J. Neurotrauma 25, 235-247. doi: 10.1089/neu.2007.0383
22. Hemphill, J. C., and Phan, N. (2013a). Management ofacute severe traumatic brain injury. Available online at: http://www.uptodate.com/contents/management-of-acute-severe-traumatic-brain-injury
23. Hemphill, J. C., and Phan, N. (2013b). Traumatic brain injury: epidemiology, classification and pathophysiology. Available online at: http://www.uptodate.com/contents/traumatic-brain-injury-epidemiology-classification-and-patho-physiology
24. Ho, K. M., Honeybul, S., Yip, C. B., and Silbert, B. I. (2014). Prognostic significance of blood-brain barrier disruption in patients with severe nonpenetrating traumatic brain injuryrequiringdecompressive craniectomy. J. Neurosurg. 121, 674-679. doi: 10.3171/2014.6.jns132838
25. Lescot, T., Fulla-Oller, L., Palmier, B., Po, C., Beziaud, T., Puybasset, L., et al. (2010). Effect of acute poly(ADP-Ribose) polymerase inhibition by 3-AB on blood-brain barrier permeability and edema formation after focal traumatic brain injury in rats. J. Neurotrauma 27, 1069-1079. doi: 10.1089/neu.2009.1188
26. Liu, N. K., Zhang, Y. P., O'Connor, J., Gianaris, A., Oakes, E., Lu, Q. B., et al. (2013). A bilateral head injury that shows graded brain damage and behavioral deficits in adultmice. Brain Res. 1499, 121-128. doi: 10.1016/j.brainres.2012.12.031
27. Loane, D. J., Pocivavsek, A., Moussa, C. E., Thompson, R., Matsuoka, Y., Faden, A. I., et al. (2009). Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury. Nat. Med. 15, 377-379. doi: 10.1038/nm.1940
28. Logsdon, A. F., Lucke-Wold, B. P., Turner, R. C., Huber, J. D., Rosen, C. L., and Simpkins, J. W. (2015). Role of microvascular disruption in brain damage from traumatic brain injury. Compr. Physiol. 5, 1147-1160. doi: 10.1002/cphy.c140057
29. Lowenstein, D. H., Thomas, M. J., Smith, D. H., and McIntosh, T. K. (1992). Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus. J. Neurosci. 12, 4846-4853
30. Lu, J., Marmarou, A., Lapane, K., Turf, E., and Wilson, L. (2010). A method for reducing misclassification in the extended glasgow outcome score. J. Neurotrauma 27, 843-852. doi: 10.1089/neu.2010.1293
31. Ma, V. Y., Chan, L., and Carruthers, K. J. (2014). Incidence, prevalence, costs and impact on disability of common conditions requiring rehabilitation in the United States: stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, osteoarthritis, rheumatoid arthritis, limb loss and back pain. Arch. Phys. Med. Rehabil. 95, 986-995. doi: 10.1016/j.apmr.2013.10.032
32. Ma, Q., Huang, B., Khatibi, N., Rolland, W. IInd, Suzuki, H., Zhang, J. H., et al. (2011). PDGFR-alpha inhibition preserves blood-brain barrier after intracerebral hemorrhage. Ann. Neurol. 70, 920-931. doi: 10.1002/ana.22549
33. Maas, A. I., Murray, G., Henney, H. IIIrd, Kassem, N., Legrand, V., Mangelus, M., et al. (2006). Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. Lancet Neurol. 5, 38-45. doi: 10.1016/s1474-4422(05)70253-2
34. Maas, A. I., Roozenbeek, B., and Manley, G. T. (2010). Clinical trials in traumatic brain injury: past experience and current developments. Neurotherapeutics 7, 115-126. doi: 10.1016/j.nurt.2009.10.022
35. Maei, H. R., Zaslavsky, K., Teixeira, C. M., and Frankland, P. W. (2009). What is the most sensitive measure of water maze probe test performance? Front. Integr. Neurosci. 3:4. doi: 10.3389/neuro.07.004.2009
36. Marion, D. W., Darby, J., and Yonas, H. (1991). Acute regional cerebral blood flowchanges caused by severe head injuries. J. Neurosurg. 74, 407-414. doi: 10.3171/jns.1991.74.3.0407
37. Marmarou, A., Nichols, J., Burgess, J., Newell, D., Troha, J., Burnham, D., et al. (1999). Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: results of a multi-center, randomized, placebo-controlled trial. American brain injury consortium study group. J. Neurotrauma 16, 431-444. doi: 10.1089/neu.1999.16.431
38. McIntosh, T. K., Vink, R., Noble, L., Yamakami, I., Fernyak, S., Soares, H., et al. (1989). Traumatic brain injury in the rat: characterization of a lateral fluid-percussion model. Neuroscience 28, 233-244. doi: 10.1016/0306-4522(89)90247-9
39. McKinney, B. C., Chow, C. Y., Meisler, M. H., and Murphy, G. G. (2008). Exaggerated emotional behavior in mice heterozygous null for the sodium channel Scn8a (Nav1.6). Genes Brain Behav. 7, 629-638. doi: 10.1111/j.1601-183X.2008.00399.x
40. Mori, T., Wang, X., Kline, A. E., Siao, C. J., Dixon, C. E., Tsirka, S. E., et al. (2001). Reduced cortical injury and edema in tissue plasminogen activator knockout mice after brain trauma. Neuroreport 12, 4117-4120. doi: 10.1097/00001756-200112210-00051
41. Perkowski, J. J., and Murphy, G. G. (2011). Deletion of the mouse homolog of KCNAB2, a gene linked to monosomy 1p36, results in associative memory impairments and amygdala hyperexcitability. J. Neurosci. 31, 46-54. doi: 10.1523/JNEUROSCI.2634-10.2011
42. Rau, P. R., Sellner, J., Heiland, S., Plaschke, K., Schellinger, P. D., Meyding-Lamade, U. K., et al. (2006). Apparent diffusion coefficient in the aging mouse brain: a magnetic resonance imaging study. Life Sci. 78, 1175-1180. doi: 10.1016/j.lfs.2005.06.032
43. Rodriguez-Gonzalez, R., Blanco, M., Rodriguez-Yanez, M., Moldes, O., Castillo, J., and Sobrino, T. (2013). Platelet derived growth factor-CC isoform is associated with hemorrhagic transformation in ischemic stroke patients treated with tissue plasminogen activator. Atherosclerosis 226, 165-171. doi: 10.1016/j.atherosclerosis.2012.10.072
44. Rutland-Brown, W., Langlois, J. A., Thomas, K. E., and Xi, Y. L. (2006). Incidence of traumatic brain injury in the United States, 2003. J. Head Trauma Rehabil. 21, 544-548. doi: 10.1097/00001199-200611000-00009
45. Sashindranath, M., Sales, E., Daglas, M., Freeman, R., Samson, A. L., Cops, E. J., et al. (2012). The tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans. Brain 135, 3251-3264. doi: 10.1093/brain/aws178
46. Shipton, O. A., El-Gaby, M., Apergis-Schoute, J., Deisseroth, K., Bannerman, D. M., Paulsen, O., et al. (2014). Left-right dissociation ofhippocampal memory processes in mice. Proc. Natl. Acad. Sci. U S A 111, 15238-15243. doi: 10.1073/pnas.1405648111
47. Shlosberg, D., Benifla, M., Kaufer, D., and Friedman, A. (2010). Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat. Rev. Neurol. 6, 393-403. doi: 10.1038/nrneurol.2010.74
48. Sinz, E. H., Kochanek, P. M., Dixon, C. E., Clark, R. S., Carcillo, J. A., Schiding, J. K., et al. (1999). Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice. J. Clin. Invest. 104, 647-656. doi: 10.1172/jci6670
49. Su, E. J., Fredriksson, L., Geyer, M., Folestad, E., Cale, J., Andrae, J., et al. (2008). Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat. Med. 14, 731-737. doi: 10.1038/nm1787
50. Swartz, B. E., Houser, C. R., Tomiyasu, U., Walsh, G. O., DeSalles, A., Rich, J. R., et al. (2006). Hippocampal cell loss in posttraumatic human epilepsy. Epilepsia 47, 1373-1382. doi: 10.1111/j.1528-1167.2006.00602.x
51. Tate, D. F., and Bigler, E. D. (2000). Fornixand hippocampal atrophy in traumatic brain injury. Learn. Mem. 7, 442-446. doi: 10.1101/lm.33000
52. Thal, S. C., and Neuhaus, W. (2014). The blood-brain barrier as a target in traumatic brain injury treatment. Arch. Med. Res. 45, 698-710. doi: 10.1016/j.arcmed.2014.11.006
53. Thurman, D. J., Alverson, C., Dunn, K. A., Guerrero, J., and Sniezek, J. E. (1999). Traumatic brain injury in the united states: a public health perspective. J. Head Trauma Rehabil. 14, 602-615. doi: 10.1097/00001199-199912000-00009
54. Washington, P. M., Forcelli, P. A., Wilkins, T., Zapple, D. N., Parsadanian, M., and Burns, M. P. (2012). The effect ofinjury severity on behavior: a phenotypic study of cognitive and emotional deficits after mild, moderate and severe controlled cortical impact injury in mice. J. Neurotrauma 29, 2283-2296.doi: 10.1089/neu.2012.2456
55. White, J. A., McKinney, B. C., John, M. C., Powers, P. A., Kamp, T. J., and Murphy, G. G. (2008). Conditional forebrain deletion of the L-type calcium channel Ca V 1.2 disrupts remote spatial memories in mice. Learn. Mem. 15, 1-5. doi: 10.1101/lm.773208
56. Witgen, B. M., Lifshitz, J., Smith, M. L., Schwarzbach, E., Liang, S. L., Grady, M. S., et al. (2005). Regional hippocampal alteration associated with cognitive deficit following experimental brain injury: a systems, network and cellular evaluation. Neuroscience 133, 1-15. doi: 10.1016/j.neuroscience.2005.01.052
57. Yepes, M., Sandkvist, M., Moore, E. G., Bugge, T. H., Strickland, D. K., and Lawrence, D. A. (2003). Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J. Clin. Invest. 112,1533-1540. doi: 10.1172/jci19212
58. Yepes, M., Sandkvist, M., Wong, M. K., Coleman, T. A., Smith, E., Cohan, S. L., et al. (2000). Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood 96, 569-576.
59. Yurkewicz, L., Weaver, J., Bullock, M. R., and Marshall, L. F. (2005). The effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injury. J. Neurotrauma 22, 1428-1443. doi: 10.1089/neu.2005.22.1428
60. Zauner, A., Bullock, R., Kuta, A. J., Woodward, J., and Young, H. F. (1996). Glutamate release and cerebral blood flowafter severe human head injury. Acta Neurochir. Suppl. 67, 40-44. doi: 10.1007/978-3-7091-6894-3_9